309 related articles for article (PubMed ID: 29159804)
1. Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.
Schroeder L; Wichmann G; Willner M; Michel A; Wiesenfarth M; Flechtenmacher C; Gradistanac T; Pawlita M; Dietz A; Waterboer T; Holzinger D
Int J Cancer; 2018 Apr; 142(7):1361-1368. PubMed ID: 29159804
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.
Schroeder L; Boscolo-Rizzo P; Dal Cin E; Romeo S; Baboci L; Dyckhoff G; Hess J; Lucena-Porcel C; Byl A; Becker N; Alemany L; Castellsagué X; Quer M; León X; Wiesenfarth M; Pawlita M; Holzinger D
Eur J Cancer; 2017 Mar; 74():73-81. PubMed ID: 28335889
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
[TBL] [Abstract][Full Text] [Related]
4. Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay.
Menegaldo A; Schroeder L; Holzinger D; Tirelli G; Dal Cin E; Tofanelli M; Rigo S; Mantovani M; Stellin M; Del Mistro A; Dei Tos AP; Guerriero A; Niero M; Borsetto D; Da Mosto MC; Polesel J; Pawlita M; Waterboer T; Boscolo-Rizzo P
Laryngoscope; 2021 May; 131(5):1042-1048. PubMed ID: 33103777
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
6. Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary.
Boscolo-Rizzo P; Schroeder L; Sacchetto V; Holzinger D; Da Mosto MC; Tirelli G; Dal Cin E; Mantovani M; Menegaldo A; Del Mistro A; Romeo S; Dei Tos AP; Niero M; Rigo S; Dyckhoff G; Hess J; Alemany L; Quer M; León X; Polesel J; Pawlita M; Bertorelle R
Head Neck; 2019 Nov; 41(11):3833-3841. PubMed ID: 31414564
[TBL] [Abstract][Full Text] [Related]
7. Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: Addition of EBV testing improves diagnostic accuracy.
Švajdler M; Kašpírková J; Hadravský L; Laco J; Dubinský P; Straka Ľ; Ondič O; Michal M; Skálová A
Pathol Res Pract; 2016 Jun; 212(6):524-31. PubMed ID: 27013059
[TBL] [Abstract][Full Text] [Related]
8. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
[TBL] [Abstract][Full Text] [Related]
9. p16 expression in cutaneous squamous carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck.
Beadle BM; William WN; McLemore MS; Sturgis EM; Williams MD
Head Neck; 2013 Nov; 35(11):1527-33. PubMed ID: 23108906
[TBL] [Abstract][Full Text] [Related]
10. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
McDowell LJ; Young RJ; Johnston ML; Tan TJ; Kleid S; Liu CS; Bressel M; Estall V; Rischin D; Solomon B; Corry J
Cancer; 2016 Apr; 122(8):1201-8. PubMed ID: 26881928
[TBL] [Abstract][Full Text] [Related]
11. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
[TBL] [Abstract][Full Text] [Related]
12. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.
Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM
Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
14. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
15. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site.
Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T
ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345
[TBL] [Abstract][Full Text] [Related]
17. Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus.
Mehrad M; Carpenter DH; Chernock RD; Wang H; Ma XJ; Luo Y; Luo J; Lewis JS; El-Mofty SK
Am J Surg Pathol; 2013 Sep; 37(9):1349-56. PubMed ID: 23797720
[TBL] [Abstract][Full Text] [Related]
18.
Cheol Park G; Roh JL; Cho KJ; Seung Kim J; Hyeon Jin M; Choi SH; Yuhl Nam S; Yoon Kim S
Int J Cancer; 2017 Mar; 140(6):1405-1412. PubMed ID: 27943271
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection.
Axelsson L; Nyman J; Haugen-Cange H; Bove M; Johansson L; De Lara S; Kovács A; Hammerlid E
J Otolaryngol Head Neck Surg; 2017 Jun; 46(1):45. PubMed ID: 28601094
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma.
Weiss D; Koopmann M; Rudack C
Head Neck; 2011 Jun; 33(6):856-62. PubMed ID: 20737490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
